Filing Details

Accession Number:
0001193805-15-001933
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-23 16:05:41
Reporting Period:
2015-11-19
Filing Date:
2015-11-23
Accepted Time:
2015-11-23 16:05:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368514 Adma Biologics Inc. ADMA Biological Products, (No Disgnostic Substances) (2836) 562590442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542517 S Adam Grossman C/O Adma Biologics, Inc.
465 State Route 17
Ramsey NJ 07446
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2015-11-19 1,000 $9.13 628,057 No 4 P Indirect Please see footnote
Common Stock, $0.0001 Par Value Per Share Acquisiton 2015-11-20 361 $9.12 628,418 No 4 P Direct
Common Stock, $0.0001 Par Value Per Share Acquisiton 2015-11-20 2,500 $9.26 630,918 No 4 P Indirect Please see footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Please see footnote
No 4 P Direct
No 4 P Indirect Please see footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.1658 per share. The reporting person undertakes to provide to ADMA Biologics, Inc., any security holder of ADMA Biologics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on November 19, 2015.
  2. 580,957 of these shares are held by Hariden, LLC, an entity for which Adam Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc.
  3. 44,200 of these shares are held by Areth LLC, an entity for which Adam Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc.
  4. These shares are being purchased by Areth LLC, an entity for which Adam Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc.
  5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.2129 to $9.40 per share. The reporting person undertakes to provide to ADMA Biologics, Inc., any security holder of ADMA Biologics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased by it at each separate price on November 20, 2015.
  6. 46,700 of these shares are held by Areth LLC, an entity for which Adam Grossman has the power to vote and dispose of the shares of common stock of ADMA Biologics, Inc.